Table 3 Disparities in diabetes prevalence, quality of care and outcomes in MHCs and non-MHCs
Measure | MHCs* | Non-MHCs | Unadjusted OR/RR (95% CI) | Adjusted OR/RR (95% CI)† |
|---|---|---|---|---|
Diabetes prevalence‡, % | 9.3% | 6.1% | 1.41 (1.37 to 1.44) | 1.40 (1.36 to 1.43) |
Receipt of recommended test at one year§, % | ||||
- HbA1c test | 37.2% | 42.9% | 0.79 (0.76 to 0.82) | 0.84 (0.80 to 0.88) |
- Microalbuminuria test | 12.6% | 15.4% | 0.79 (0.74 to 0.84) | 0.76 (0.71 to 0.82) |
- Blood lipid test | 24.3% | 29.5% | 0.77 (0.73 to 0.80) | 0.81 (0.77 to 0.85) |
- Any test | 46.4% | 53.2% | 0.76 (0.73 to 0.80) | 0.81 (0.78 to 0.85) |
Receipt of recommended test during the entire follow-up period, rate per person per year | ||||
- HbA1c test | 0.62 | 0.68 | 0.89 (0.86 to 0.91) | 0.88 (0.86 to 0.90) |
- Microalbuminuria test | 0.24 | 0.27 | 0.86 (0.83 to 0.89) | 0.82 (0.80 to 0.85) |
- Blood lipid test | 0.40 | 0.44 | 0.90 (0.88 to 0.93) | 0.90 (0.88 to 0.93) |
- All tests | 1.25 | 1.38 | 0.88 (0.86 to 0.90) | 0.86 (0.84 to 0.88) |
First hospitalisation for diabetes complications, % | 45.2% | 45.0% | 1.08 (1.05 to 1.12) | 1.20 (1.17 to 1.24) |
Diabetes related mortality, % | 11.8% | 11.1% | 1.08 (1.02 to 1.15) | 1.43 (1.35 to 1.52) |
All cause mortality, % | 30.4% | 27.1% | 1.14 (1.10 to 1.19) | 1.47 (1.42 to 1.53) |
Entire follow-up time, y, mean (SD) | 10.5 (5.9) | 10.8 (5.6) |